查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1425108

破坏性行为障碍治疗市场 – 2024 年至 2029 年预测

Disruptive Behavior Disorder Treatment Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计破坏性行为障碍治疗市场在预测期内将以 5.82% 的复合年增长率成长。

破坏性行为障碍是一组具有频繁烦躁、粗鲁、言语不守规矩和攻击性行为等症状的疾病，可能会损害社交、家庭和个人功能。这些包括品行障碍、对立障碍和间歇性爆发性障碍。有多种治疗方法可以治疗这种病理，包括家庭治疗、团体治疗以及提高患者社交和情绪技能的培训。

破坏性行为障碍治疗市场的推动要素

影响破坏性行为障碍治疗市场成长的主要因素是破坏性行为障碍治疗的进步以及对心理健康问题早期诊断的认识的提高。新兴市场的巨大潜力，包括改善的医疗基础设施和不断增加的未满足的医疗需求，也正在推动破坏性行为障碍治疗产业的发展。此外，由于政府投资增加、对增强医疗服务的需求增加以及医疗旅游的兴起，新兴国家的医疗保健产业正在不断发展。

破坏性行为障碍的盛行率

破坏性行为障碍是一种影响儿童并导致他们对他人表现出攻击性、不合作和挑衅行为的障碍。破坏性行为障碍盛行率的增加、更快的反应和周转时间、更好的诊断、非侵入性治疗程序、电脑支援的可用性以及对大量诊断产品的依赖正在增加破坏性行为障碍的盛行率。残疾治疗市场。根据美国儿童与青少年精神医学会的数据，对立障碍影响 1% 至 16% 的青少年和学龄儿童。这种疾病在男性中比在女性中更常见。

对儿童心理健康措施的需求不断增长

各种非政府组织的参与不断增加以及对破坏性行为障碍治疗的认识不断提高，正在推动破坏性行为障碍治疗市场的成长。例如，启动了调查计画，旨在培训家长治疗儿童破坏性行为障碍并预防对立对立障碍 (ODD)。此外，人工智慧（AI）与儿科崩坏疾病治疗的结合正在创造进一步的成长机会。这使得孩子们能够在相关医生的持续指导下应对压力情况。

药物管理越来越受欢迎

药物用于治疗对立和行为障碍。对于这些情况，需要使用各种合成药物和草药来为大脑和神经提供适当的刺激。小组会议、教养方式调整和情绪技能训练等治疗在早期阶段更为有益，因此在后期阶段才考虑使用这些药物。这些因素影响预测期内治疗的成长，并有助于破坏性行为障碍治疗市场的成长。此外，在许多情况下，由于患者不了解自己的症状，导致治疗延误并需要药物管理。

以客户为中心的治疗越来越受欢迎

以客户为中心的治疗方法透过关注病人来改变破坏性行为障碍的外在症状。目的是鼓励该人以更适当的方式行事。在以客户为中心的治疗中，患者与治疗师进行一对一或小组互动，以培养必要的技能。放鬆技巧和愤怒管理技巧只是以客户为中心的治疗中教授的应对策略的几个例子。

在北美，破坏性行为障碍治疗市场预计将稳定成长。

由于儿童和成人行为障碍的盛行率不断增加，预计北美的破坏性行为障碍治疗产业将在预测期内成长。随着人们越来越意识到其症状，破坏性行为障碍治疗市场预计将在该地区成长。例如，犹他州的高地岭医院举办家长教育课程，向家长介绍破坏性行为障碍治疗的早期症状。这些倡议预计将有助于该地区的市场成长。此外，由于目标人口不断增长以及成年人药物滥用现像日益普遍，亚太地区被认为是破坏性行为障碍治疗产业成长第二快的地区。

破坏性行为障碍治疗计划

  • 家长计画：该计划帮助父母在孩子寻求帮助或关注时做出适当的反应。
  • 儿童计画：该计画帮助孩子对家人和自己感到更加乐观，提高他们的人际互动、沟通和分析能力，帮助他们更好地管理愤怒和情绪沟通。
  • 青少年计画：此计画鼓励父母花更多时间陪伴青少年。
  • 教师计画：该计画培训教师控制学生在课堂上的行为。透过提高孩子的情感和社交智力并与他们一起工作，让父母参与其中。

破坏性行为障碍治疗药物

  • 兴奋剂，FDA 已批准兴奋剂用于治疗过动症。
  • 非刺激性 ADHD 药物，FDA 已批准使用胍法辛 ER (Intuniv®) 和托莫西汀 (Strattera®) 治疗 ADHD。
  • 抗惊厥药物 FDA 已核准抗惊厥药物双丙戊酸钠（Depakene®、Depakote®、Depakote ER®）用于治疗癫痫发作。
  • 抗精神病药物：FDA 已核准抗精神病药物用于治疗精神病（一种精神疾病）。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表

第二章调查方法

  • 调查资料
  • 先决条件

第三章执行摘要

  • 研究亮点

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析

第五章破坏性行为障碍治疗市场：依类型

  • 介绍
  • 破坏性行为障碍
  • 品行障碍
  • 间歇性爆发性障碍

第六章破坏性行为障碍治疗市场：依治疗分类

  • 介绍
  • 用药管理
  • 综合评价
  • 育儿疗法
  • 团体治疗
  • 个别治疗

第七章破坏性行为障碍治疗市场：依最终使用者分类

  • 介绍
  • 医院
  • 诊所
  • 其他的

第八章破坏性行为障碍治疗市场：按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 其他的
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第九章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 供应商竞争力矩阵

第十章 公司简介

  • Valley Behavioural Health
  • Piney Ridge Treatment Center
  • The Recovery Village
  • Highland Ridge Hospital
  • Sierra Tucson
  • Behavioural Neurotherpay Clinic
  • Cross Creek Hospital
  • Mayo Clinic
  • Mind Plus
  • Kennedy Krieger Institute
简介目录
Product Code: KSI061616212

The disruptive behavior disorder treatment market is estimated to grow at a CAGR of 5.82% during the forecast period.

Disruptive behaviour disorders are a group of disorders with symptoms like frequent temper, rudeness, speaking harshly, and aggressive behavior which can impair social, familial, and personal functioning. These include conduct disorder, defiant disorder, and intermittent explosive disorder. To treat this condition there are various therapies available including family therapy, group therapy, and training which are given to patients to improve their social and emotional skills.

Driving factors for the disruptive behavior disorder treatment market

The major factor influencing the growth of the disruptive behavior disorder treatment market is the advancement in disruptive behavior disorder treatment in addition to raising awareness related to early diagnosis of mental health issues. The high potential in emerging markets with the improvement in healthcare infrastructure, and increase in unmet medical needs is also driving the disruptive behavior disorder treatment industry. Moreover, the healthcare industry in emerging countries is developing owing to the growing investment by the government of various nations, the increase in demand for enhanced healthcare services, and the rising medical tourism.

Growing prevalence of oppositional defiant disorder

Oppositional defiant disorder is a condition that affects children, and they behave in an aggressive, uncooperative, and defiant manner with others. The increasing prevalence of the oppositional defiant disorder, faster response and turnaround time, better diagnosis, non-invasive treatment procedures, availability of computational support, and reliance on the substantial number of diagnostic products are fueling the disruptive behavior disorder treatment market growth. According to the American Academy of Child & Adolescent Psychiatry, oppositional defiant disorder affects 1% to 16% of adolescents and school-aged children. Males are more likely to have the condition diagnosed than females.

Rising need to address children's mental health

The growing involvement of various NGOs and rising awareness of disruptive behaviour disorder treatment are fueling the disruptive behavior disorder treatment market growth. For instance, a research program named Strongest Families Finland Canada (SFFC) Smart Website was launched to train parents about disruptive behaviour disorder among children to prevent Oppositional Defiant Disorder (ODD). Furthermore, the integration of disruptive disorder treatment for children with Artificial Intelligence (AI) is creating more growth opportunities. This will help children cope with stressful situations with continuous guidance from concerned doctors.

Medication management is gaining popularity

Medication management is used for treating oppositional defiant and conduct disorders. In these conditions, various synthetic and herbal drugs are prescribed for proper brain and nervous stimulation. These medications are considered in the later stages as therapies are more beneficial in the primary stage, such as group sessions, parenting modifications, and emotional skills training. These factors are influencing the growth of therapies during the forecast period which contributes to disruptive behavior disorder treatment market growth. Furthermore, there are multiple cases where the patient is unaware of the symptoms and there are delays in treatment which leads to the use of medication management.

Increasing popularity of client-focused treatments

Client-focused therapies alter the outward manifestations of a disruptive behavior disorder by focusing on the patient with the disease. The intention is to encourage the person to act in more suitable ways. In client-focused therapies, the patient interacts with a therapist one-on-one or in a group setting to acquire the necessary skills. Relaxation techniques and anger management techniques are only a couple of the coping mechanisms that may be taught in client-centred therapies.

In North America, it is projected that the disruptive behavior disorder treatment market will grow steadily.

The disruptive behaviour disorder treatment industry is anticipated to grow in North America during the projected period due to the increasing prevalence of behavioural disorders among children and adults. As people become more aware of the symptoms the disruptive behavior disorder treatment market is anticipated to grow in the region. For instance, learning sessions for parents to impart knowledge of early symptoms of disruptive behavior disorder are being conducted by the Highland Ridge Hospital of Utah. Such initiatives are predicted to contribute to the growth of the market in the region. Additionally, Asia Pacific is considered to be the second largest growing disruptive behavior disorder treatment industry owing to the increasing target population and growing substance abuse among adults.

Disruptive behavior disorder treatment programs

  • Parent Programs, this program encourages parents to respond in a good manner when their youngster requests assistance or attention. Set attainable objectives for the child and better keep an eye on the child's actions.
  • Child Programs, program help children feel more optimistic about their family and themselves enhancing their interpersonal, communicative, and analytical abilities to better manage anger and emotional communication
  • Teen Programs, this program influences parents to spend extra time with their teens. Clearly define the rules and the penalties for breaching them.
  • Teacher Programs, this program trains teachers to control student behavior in the classroom. Boost the emotional and social intelligence of kids and keep the parents involved by working with them.

Disruptive behavior disorder treatment medicines

  • Stimulants, For the treatment of ADHD, the FDA has authorised stimulants. They are also used by certain medical practitioners to treat DBDs.
  • Nonstimulant ADHD medicines, The FDA has authorised the use of guanfacine ER (Intuniv®) and atomoxetine (Strattera®) to treat ADHD.
  • Anticonvulsant medicine, The FDA has given the anticonvulsant drug divalproex (Depakene®, Depakote®, and Depakote ER®) approval to treat seizures.
  • Antipsychotics, The FDA has given the drug antipsychotics approval to treat psychosis, a kind of mental disease.

Market Key Developments

  • In October 2022, The Anna Freud Centre's thorough analysis of worldwide research demonstrated the beneficial effects of treatments on young children and their careers.
  • In October 2022, Lupin announced the release of Paliperidone Extended-Release Tablets, a generic version of Janssen Research and Development's Invega Extended-Release Tablets.
  • In January 2022, Bionomics began the mid-stage BNC210 study to treat social anxiety disorder.

Segmentation:

By Type

  • Oppositional Defiant Disorder
  • Conduct Disorder
  • Intermittent Explosive Disorder

By Treatment

  • Medication Management
  • Comprehensive Evaluation
  • Parenting Therapy
  • Group Therapy
  • Individual Therapy

By End-User

  • Hospitals
  • Clinics
  • Others

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Assumptions

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Force Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. DISRUPTIVE BEHAVIOR DISORDER TREATMENT MARKET, BY TYPE

  • 5.1. Introduction
  • 5.2. Oppositional Defiant Disorder
  • 5.3. Conduct Disorder
  • 5.4. Intermittent Explosive Disorder

6. DISRUPTIVE BEHAVIOR DISORDER TREATMENT MARKET, BY TREATMENT

  • 6.1. Introduction
  • 6.2. Medication Management
  • 6.3. Comprehensive Evaluation
  • 6.4. Parenting Therapy
  • 6.5. Group Therapy
  • 6.6. Individual Therapy

7. DISRUPTIVE BEHAVIOR DISORDER TREATMENT MARKET, BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Clinics
  • 7.4. Others

8. DISRUPTIVE BEHAVIOR DISORDER TREATMENT MARKET, BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. United States
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. United Kingdom
    • 8.4.2. Germany
    • 8.4.3. France
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. The Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Israel
    • 8.5.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES

  • 10.1. Valley Behavioural Health
  • 10.2. Piney Ridge Treatment Center
  • 10.3. The Recovery Village
  • 10.4. Highland Ridge Hospital
  • 10.5. Sierra Tucson
  • 10.6. Behavioural Neurotherpay Clinic
  • 10.7. Cross Creek Hospital
  • 10.8. Mayo Clinic
  • 10.9. Mind Plus
  • 10.10. Kennedy Krieger Institute